Here's 1 High-Yield Dividend Stock to Consider Buying
Equity markets have been volatile thus far in 2022.
For various reasons, including red-hot inflation, supply chain woes, and investors' fears of a potential recession, the S&P 500 index is now down nearly 11% year to date. Not surprisingly, this has led many traders to shift assets into stocks that are viewed as safe havens -- among them, well-established dividend-paying stocks.
This, in part, explains why pharma company Novartis (NYSE: NVS) has done so well. Its shares are up 1.5% year to date. Despite this recent outperformance, I believe Novartis is still a buy based on its fundamentals and valuation.
Source Fool.com
